Regarding the pharmacological profiles and clinical uses of modern heart failure drugs, all of the following are true EXCEPT:

Explanation

## Modern Heart Failure Pharmacotherapy ### Correct Statements (Options 0, 1, 3) **High-Yield:** SGLT2 inhibitors, ARNIs, and hydralazine-nitrate combinations all have proven mortality/morbidity benefits in specific HF populations. | Drug Class | Mechanism | Indication | Evidence | |---|---|---|---| | SGLT2 Inhibitors | ↓ Preload, ↓ afterload, ↑ myocardial efficiency | HFrEF + HFpEF | DAPA-HF, EMPEROR-Reduced, DELIVER | | ARNI (Sacubitril/Valsartan) | Neprilysin inhibition + AT1 blockade | HFrEF (Class IIa) | PARADIGM-HF | | Hydralazine-Nitrate | Direct vasodilation | HFrEF (African American, ACE-I intolerant) | A-HeFT trial | **Key Point:** SGLT2 inhibitors are now recommended for both **reduced and preserved EF**, making them one of the broadest-spectrum HF drugs. ### Why Option 2 Is Incorrect **Warning:** Ivabradine is NOT first-line therapy and does NOT reduce mortality in systolic HF. **Clinical Pearl:** Ivabradine is a selective I_f (funny current) channel inhibitor that reduces heart rate in sinus rhythm. However: - It is **NOT indicated as first-line** therapy in HFrEF. - It does **NOT improve survival** — it is used only for **symptom relief** in patients with elevated resting heart rate (≥70 bpm) despite beta-blocker therapy. - It is a **second-line agent** for rate control in HF with preserved sinus rhythm. - The SHIFT trial showed ivabradine reduced hospitalizations but NOT mortality. **Key Point:** Ivabradine is **NOT a disease-modifying drug** — it is a rate-limiting agent for symptomatic relief. It should never be used as monotherapy or first-line in any HF patient. ### Mnemonic: HF Drugs by Mortality Benefit **Mortality Reducers (First-Line GDMT):** - ACE-I / ARB - Beta-blockers - Aldosterone antagonists - SGLT2 inhibitors - ARNI (sacubitril/valsartan) - Hydralazine-nitrate (in specific populations) **Symptom Relief Only (No Mortality Benefit):** - Diuretics - Ivabradine - Nitrates (monotherapy) - Inotropes (short-term only) **Tip:** On NEET PG, always ask: "Does this drug reduce mortality or just relieve symptoms?" Ivabradine is a classic trap — it sounds like a modern HF drug but is purely symptomatic.